Vivo Opportunity, Llc - Net Worth and Insider Trading

Vivo Opportunity, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Opportunity, Llc owns 8 companies in total, including ALX Oncology Holdings Inc (ALXO) , Crinetics Pharmaceuticals Inc (CRNX) , and Sierra Oncology Inc (SRRA) among others .

Click here to see the complete history of Vivo Opportunity, Llc’s form 4 insider trades.

Insider Ownership Summary of Vivo Opportunity, Llc

Ticker Comapny Transaction Date Type of Owner
ALXO ALX Oncology Holdings Inc 2020-07-21 10 percent owner
CRNX Crinetics Pharmaceuticals Inc 2020-01-29 10 percent owner
SRRA Sierra Oncology Inc 2019-11-22 10 percent owner
LIMIT LIMIT 2019-01-07 10 percent owner
LIMIT LIMIT 2021-02-09 10 percent owner
LIMIT LIMIT 2022-08-12 10 percent owner
LIMIT LIMIT 2023-10-02 10 percent owner
LIMIT LIMIT 2023-08-09 10 percent owner

Vivo Opportunity, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivo Opportunity, Llc Ownership Network

Ownership Network List of Vivo Opportunity, Llc

No Data

Ownership Network Relation of Vivo Opportunity, Llc

Insider Network Chart

Vivo Opportunity, Llc Owned Company Details

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Vivo Opportunity, Llc is the 10 percent owner of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Vivo Opportunity, Llc made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .

In summary, during the past 3 months, insiders sold 3,866 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 3,866 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ALX Oncology Holdings Inc Insider Transactions

No Available Data

Vivo Opportunity, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Opportunity, Llc. You might contact Vivo Opportunity, Llc via mailing address: 192 Lytton Avenue, Palo Alto Ca 94301.